Now is the time for independent pharmacies to shine online.
Kevin W. Cleveland, PharmD, urges evidence-based approaches to immunizations in an era of uncertainty.
Pharmacogenomics looks at how genetic influences affect an individual’s response to therapeutic medications.
Companies like ShiftRx are using technology to help solve the staffing shortage crisis in health care.
The FDA approved ceftobiprole medocaril sodium for injection (Zevtera) in April 2024.
The Summit provides a rare opportunity for professionals to dive deep into emerging healthcare technologies and treatment models.
How are hiring trends shaping up for the future of health care?
On January 6, 2023, the FDA granted lecanemab-irmb (Leqembi) accelerated approval for treating mild cognitive impairment and mild dementia in patients with Alzheimer disease.
Ser/dex is a dexmethylphenidate-based prodrug for ADHD in patients 6 years and older.
Stanley V. Campbell, Jr., CEO of EagleForce Associates, Inc., and Yi Deng, PhD, Senior Vice President of Engineering at EagleForce, discuss the basics of AI and how it’s assisting with compliance.
Disadvantaged groups are feeling the sting of health care costs—so much so that many are foregoing health care because they can’t pay for it.
What pharmacists need to consider before selling CBD in their stores.
Many individuals have been asking if they can take things at home, such as vitamins and OTC medications, to decrease their risk of contracting the virus or to self-treat themselves
Apetamin has been promoted worldwide as a weight gain supplement—but what are the dangers of misuse?
Tips to help your pharmacy stand out as a knowledgeable CBD retailer.
Chronic pain is associated with a significant financial burden, with an estimated cost placed at $650 billion annually in the US.
At the state level, medication treatment rates ranged from 17.7% in Kansas to 82.8% in Maine.
Crystal Lennartz, president of Health Mart & Health Mart Atlas at McKesson, discusses challenges that independent pharmacies are facing in today's health care landscape.
The researchers reported that there was no significant difference in the age-related macular degeneration prevalence among the 3 study groups.
Tryvio was given FDA approval on March 19, 2024.
Razanne Oueini, PharmD, MSc, CPHQ, discusses how rates of persistence to basal insulin were impacted after the IRA monthly cap.
Cancer care is expensive, but pharmacists can help.
The majority of persistent irAEs were hypothyroid, adrenal insufficiency, arthritis, dermatitis or pruritis, and hypophysitis.
In this article, we will review the evidence describing a possible link between vitamin D and COVID-19.
How pharmacies will pay for the Medicare Drug Price Negotiation Program